EpiCypher Inc.

EpiCypher Inc. EpiCypher is a bioscience company developing unique reagents and services for chromatin biology and epigenetics research.

A pioneer in the field of epigenetics and chromatin biology, EpiCypher is a bioscience company developing transformative technologies and delivering superior products to researchers world-wide. Our technologies and products are making studies possible that were not imaginable just a few years ago. Our innovation is a direct result of the scientific power associated with EpiCypher. Our renowned chromatin researchers possess expertise and unique insight into epigenetics that benefit our customers in ways other companies cannot. Arising from an abundance of demand for high quality products from the laboratories of Mark Bedford, Brian Strahl, and Or Gozani EpiCypher was founded on January 18, 2012 as a spin-out from University of North Carolina at Chapel Hill. Starting with the groundbreaking and proprietary histone peptide array platform, EpiGold™, EpiCypher has developed a wide portfolio of best in class products. EpiCypher's mission is to develop products to enable researchers to complete experiments that are not otherwise possible.

⏳ One week out!Ready to rethink how you evaluate transgene integration and regulation?Join us Dec 3 for a free webinar f...
11/26/2025

⏳ One week out!

Ready to rethink how you evaluate transgene integration and regulation?

Join us Dec 3 for a free webinar featuring Zach Freeman, DVM, PhD (University of Michigan) and Emily Madden, PhD (EpiCypher). You’ll learn how Fiber-seq and PureTarget™ reveal the full story of transgenic model alterations.

🔬 Sign up today: https://app.livestorm.co/epicypher/combining-fiber-seq-and-puretarget

How do reader proteins interact with chromatin to regulate biological processes?📢 A new study in Nucleic Acids Research ...
11/25/2025

How do reader proteins interact with chromatin to regulate biological processes?

📢 A new study in Nucleic Acids Research shows how nucleosome context shapes chromatin reader specificity — a key insight for understanding disease mechanisms and therapeutic targeting.

Why it matters:
Reader binding to histone PTMs underlies gene regulation, but most studies rely on histone peptides, which capture only part of the story. Peptides can’t reveal multivalent engagement mechanisms or nucleosome architecture, both essential for accurate reader profiling.

Key takeaways:

🔹 EpiCypher developed Captify™, a platform for rapid, sensitive, and robust screening of chromatin-associated proteins against fully defined peptide and nucleosome substrates.

🔹 Reader domains bind differently on nucleosomes vs. peptides, highlighting a major limitation of peptide-only screens.

🔹 In vitro nucleosome preferences were validated in vivo using reader–CUT&RUN genomic mapping.

EpiCypher’s Captify™ platform and CUTANA™ CUT&RUN were central to dissecting these nucleosome-dependent mechanisms — offering a more complete view of how chromatin readers interpret the histone code.

📄 Read the full paper: https://pubmed.ncbi.nlm.nih.gov/41182902/

Transgenic models often hold surprises you don’t want to miss.Join us next Tuesday, Dec 3 at 3 PM ET, for a free webinar...
11/21/2025

Transgenic models often hold surprises you don’t want to miss.

Join us next Tuesday, Dec 3 at 3 PM ET, for a free webinar on using Fiber-seq and PureTarget™ to uncover hidden integration and regulation patterns. Zach Freeman, DVM, PhD (University of Michigan) and Emily Madden, PhD (EpiCypher) will share data and tips you can apply in your own research.

👉 Sign up today: https://app.livestorm.co/epicypher/combining-fiber-seq-and-puretarget

🧬

SfN 2025 is a wrap! 🧬🧠Thanks for stopping by to explore Fiber-seq, CUTANA™ Cloud, and our poster on chromatin mapping fr...
11/20/2025

SfN 2025 is a wrap! 🧬🧠

Thanks for stopping by to explore Fiber-seq, CUTANA™ Cloud, and our poster on chromatin mapping from FFPE samples in neuroscience.
We had some amazing conversations and can’t wait to share more.

Live from  ! Here’s Aaron Alcala presenting his poster on using CUTANA™ CUT&Tag to profile chromatin and transcriptional...
11/19/2025

Live from ! Here’s Aaron Alcala presenting his poster on using CUTANA™ CUT&Tag to profile chromatin and transcriptional states in FFPE tissues, a long-standing hurdle in neuroscience research.

CUT&Tag now opens access to vast FFPE archives, enabling new epigenetic insights into brain development and disease.

📄 Catch the full poster here: https://explore.epicypher.com/posters/sfn2025/advance-neuroscience-research

We’re honored to have attended the MSKCC Epigenetics Meeting at Memorial Sloan Kettering Cancer Center. The event showca...
11/19/2025

We’re honored to have attended the MSKCC Epigenetics Meeting at Memorial Sloan Kettering Cancer Center. The event showcased incredible science across NYC institutions and featured a moving keynote from Dr. Tony Kouzarides, marking his retirement.

A huge thank-you to Dr. Yael David for organizing this impactful meeting—it’s a celebration of everything we value in epigenetics research.

🔬 Webinar Alert!Confirming successful transgene integration — and whether it’s actually expressed — has long been a chal...
11/18/2025

🔬 Webinar Alert!

Confirming successful transgene integration — and whether it’s actually expressed — has long been a challenge for researchers developing transgenic animal models. Traditional sequencing and expression assays only tell part of the story.

Join us for an upcoming webinar featuring Zach Freeman, DVM, PhD (University of Michigan) who will show how his lab is using Fiber-seq in combination with PacBio's PureTarget™ to gain a complete picture of transgene integration and regulation. Additionally, Emily A. Madden, PhD (Product Manager, EpiCypher) will provide practical tips for getting started with Fiber-seq and highlight additional applications for this powerful technology.

📅 Details:
Combining PureTarget and Fiber-seq to Discover Hidden Alterations in Genome Engineered Models
12/3 @ 3 PM EST

Register Today: https://app.livestorm.co/epicypher/combining-fiber-seq-and-puretarget

Archived FFPE tissues are a treasure trove for clinical and neuroscience research, but performing chromatin profiling in...
11/18/2025

Archived FFPE tissues are a treasure trove for clinical and neuroscience research, but performing chromatin profiling in these samples has long been technically challenging.

Visit our poster at to learn how innovations in CUT&Tag technology are opening new doors to study both the epigenetic and transcriptional landscapes of FFPE tissues.

Can’t attend? View Aaron Alcala’s poster here: https://explore.epicypher.com/posters/sfn2025/advance-neuroscience-research

Day 2 of   is a wrap! Now, we're energized for Day 3! ⚡Missed us yesterday? Don't worry! Stop by Booth  #901 TODAY to se...
11/18/2025

Day 2 of is a wrap! Now, we're energized for Day 3! ⚡

Missed us yesterday? Don't worry! Stop by Booth #901 TODAY to see our NEW product and learn how it's accelerating neuroscience research! Fiber-seq is the tech designed to uncover the epigenetic changes underlying neural development, function, and disease. Study chromatin, DNA methylation, and protein footprinting—all in a single, streamlined assay.

We had a great first day at  ! 🙌From in-depth conversations about chromatin mapping to connecting with passionate neuros...
11/17/2025

We had a great first day at ! 🙌
From in-depth conversations about chromatin mapping to connecting with passionate neuroscientists, Day 1 was full of energy and insight.

We’re ready for more today. Stop by our booth to chat CUTANA™ assays, epigenetic profiling, and what’s next in chromatin research. See you there!

Address

6 Davis Drive
Durham, NC
27709

Alerts

Be the first to know and let us send you an email when EpiCypher Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to EpiCypher Inc.:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram